CAMBRIDGE, Mass.--(BUSINESS WIRE)--
April 10, 2012--Metabolix, Inc. (NASDAQ:MBLX), a bioscience company
focused on bringing clean, sustainable solutions to the plastics,
chemicals and energy industries, announced today that it will be
releasing its first quarter fiscal 2012 financial results after the
market close on Thursday, April 26, 2012. The full text of the earnings
release will also be available on the Company's website at www.metabolix.com.
Richard Eno, the Company's President and CEO, Joseph Hill, CFO, and
Oliver Peoples, Co-founder and CSO, will host a conference call on the
same day at 4:30 p.m. (Eastern) to discuss the results of the first
quarter ended March 31, 2012. The Company will also provide an update on
the business and answer questions from the investment community. A live
webcast of the call with slides can be accessed through the Company's
website at www.metabolix.com
in the investor relations section. To participate in the call, dial
toll-free 1-888-417-8519 or 719-325-2115 (international). The pass code
is 3078349.
To listen to a telephonic replay of the conference call, dial toll-free
1-877-870-5176 or 1-858-384-5517 (international) and enter pass code
3078349. The replay will be available beginning at 7:30 p.m. (Eastern)
on Thursday, April 26, 2012 and will last through 11:59 PM (Eastern) May
10, 2012. In addition, the webcast will be archived on the Company's
website in the investor relations section.
About Metabolix
Founded in 1992, Metabolix, Inc. is an innovation-driven bioscience
company focused on providing sustainable solutions for the world's needs
for plastics, chemicals and energy. The Company is taking a systems
approach, from gene to end product, integrating sophisticated
biotechnology with advanced industrial practice. Metabolix is developing
biosourced industrial chemicals and plastics, as well as a proprietary
platform technology for co-producing plastics, chemicals and energy from
crops.
For more information, please visit www.metabolix.com.
(MBLX-E)
Metabolix General Inquiries:
Lynne H. Brum, 617-682-4693
LBrum@metabolix.com
or
Investor
Relations Contact:
James R. Palczynski, ICR, 203-682-8229
james.palczynski@icrinc.com
Source: Metabolix, Inc.
News Provided by Acquire Media
